Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group.

Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.

2.

Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.

Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC, Bernstein JL; WECARE Study Collaborative Group, Begg CB.

Genet Epidemiol. 2011 Jul;35(5):389-97. doi: 10.1002/gepi.20587. Epub 2011 Apr 25.

3.

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.

Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH, Malone KE, Mellemkjaer L, Borresen-Dale AL, Rosenstein BS, Teraoka SN, Diep AT, Smith SA, Capanu M, Reiner AS, Liang X, Gatti RA, Concannon P; WECARE Study Collaborative Group.

J Natl Cancer Inst. 2010 Apr 7;102(7):475-83. doi: 10.1093/jnci/djq055. Epub 2010 Mar 19.

4.

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study.

Poynter JN, Langholz B, Largent J, Mellemkjaer L, Bernstein L, Malone KE, Lynch CF, Borg A, Concannon P, Teraoka SN, Xue S, Diep AT, Törngren T, Begg CB, Capanu M, Haile RW; WECARE Study Collaborative Group, Bernstein JL.

Cancer Causes Control. 2010 Jun;21(6):839-46. doi: 10.1007/s10552-010-9510-0. Epub 2010 Feb 4.

5.

Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.

Bernstein JL, Teraoka S, Haile RW, Børresen-Dale AL, Rosenstein BS, Gatti RA, Diep AT, Jansen L, Atencio DP, Olsen JH, Bernstein L, Teitelbaum SL, Thompson WD, Concannon P; WECARE Study Collaborative Group.

Hum Mutat. 2003 May;21(5):542-50.

PMID:
12673797
6.

The MnSOD A16V mitochondrial targeting sequence polymorphism is not associated with increased risk of distal colorectal adenomas: data from a sigmoidoscopy-based case control study.

Levine AJ, Elkhouly E, Diep AT, Lee ER, Frankl H, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1140-1. No abstract available.

7.

Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue.

Bernstein JL, Thompson WD, Casey G, DiCioccio RA, Whittemore AS, Diep AT, Thakore SS, Vaziri S, Xue S, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):809-14.

8.

An association between genetic polymorphisms in the ileal sodium-dependent bile acid transporter gene and the risk of colorectal adenomas.

Wang W, Xue S, Ingles SA, Chen Q, Diep AT, Frankl HD, Stolz A, Haile RW.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):931-6.

9.

Aromatase and breast cancer susceptibility.

Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, Henderson BE.

Endocr Relat Cancer. 1999 Jun;6(2):165-73.

PMID:
10731105
10.

Linkage analysis and loss of heterozygosity for chromosome arm 1p in familial breast cancer.

Millikan RC, Ingles SA, Diep AT, Xue S, Zhou N, Florentine BD, Sparkes RS, Haile RW.

Genes Chromosomes Cancer. 1999 Aug;25(4):354-61.

PMID:
10398429
11.

Chromosomal organization of mammalian POU domain factors.

Xia YR, Andersen B, Mehrabian M, Diep AT, Warden CH, Mohandas T, McEvilly RJ, Rosenfeld MG, Lusis AJ.

Genomics. 1993 Oct;18(1):126-30.

PMID:
8276396

Supplemental Content

Support Center